Tuesday, September 19, 2017

Collection of Scientific Studies on Vaccine Dangers

Collected by Wade Friesen 

Adverse Events following 12 and 18 Month Vaccinations: a Population-Based, Self-Controlled Case Series Analysis

A dose-response relationship between organic mercury exposure from thimerosal-containing vaccines and neurodevelopmental disorders.

Relative trends in hospitalizations and mortality among infants by the number of vaccine doses and age, based on the Vaccine Adverse Event Reporting System (VAERS), 1990-2010.

Is infant immunization a risk factor for childhood asthma or allergy?

Infant mortality rates regressed against number of vaccine doses routinely given: Is there a biochemical or synergistic toxicity?

Infection, vaccines and other environmental triggers of autoimmunity.

Comparison of Blood and Brain Mercury Levels in Infant Monkeys Exposed to Methylmercury or Vaccines Containing Thimerosal

DTP with or after measles vaccination is associated with increased in-hospital mortality in Guinea-Bissau.

Measles outbreak in a vaccinated school population: epidemiology, chains of transmission and the role of vaccine failures.

A positive association found between autism prevalence and childhood vaccination uptake across the U.S. population.

Hepatitis B vaccination of male neonates and autism diagnosis, NHIS 1997-2002.

Abnormal measles-mumps-rubella antibodies and CNS autoimmunity in children with autism.

The plausibility of a role for mercury in the etiology of autism: a cellular perspective

Detection of RNA of Mumps Virus during an Outbreak in a Population with a High Level of Measles, Mumps, and Rubella Vaccine Coverage

A case series of children with apparent mercury toxic encephalopathies manifesting with clinical symptoms of regressive autistic disorders.

Aluminum in the central nervous system (CNS): toxicity in humans and animals, vaccine adjuvants, and autoimmunity.

Unvaccinated Children are Healthier

Self-Organized Criticality Theory of Autoimmunity

Combination measles-mumps-rubella-varicella vaccination and the risk of febrile seizure.

Impact of environmental factors on the prevalence of autistic disorder after 1979

Effectiveness of trivalent inactivated influenza vaccine in influenza-related hospitalization in children: a case-control study.

Speciation of methyl- and ethyl-mercury in hair of breastfed infants acutely exposed to thimerosal-containing vaccines.

Comparison of VAERS fetal-loss reports during three consecutive influenza seasons

Impact of influenza vaccination on seasonal mortality in the US elderly population.

Effect of Routine Vaccination on Aluminum and Essential Element Levels in Preterm Infants

Polio programme: let us declare victory and move on.

[Major measles epidemic in the region of Quebec despite a 99% vaccine coverage]

Pertussis epidemic despite high levels of vaccination coverage with acellular pertussis vaccine.

Vaccination history and risk of non-Hodgkin lymphoma: a population-based, case-control study

Varicella Zoster Virus DNA at Inoculation Sites and in Saliva After Zostavax Immunization

Transmission of varicella-vaccine virus from a healthy 12-month-old child to his pregnant mother.
react-text: 5657 http://www.ncbi.nlm.nih.gov/pubmed/9255208 /react-text 

Transmission of vaccine strain varicella-zoster virus from a healthy adult with vaccine-associated rash to susceptible household contacts.
react-text: 5663 http://www.ncbi.nlm.nih.gov/pubmed/9333170 /react-text 

Transmission of varicella-zoster virus from a vaccinee with leukemia, demonstrated by polymerase chain reaction.
react-text: 5669 http://www.ncbi.nlm.nih.gov/pubmed/8201480

Detection of measles virus RNA in urine specimens from vaccine recipients.

Detection of measles vaccine in the throat of a vaccinated child.

Reversion of Cold-adapted Live Attenuated Influenza Vaccine into a Pathogenic Virus.

Acute Disseminated Encephalomyelitis following Vaccination against Hepatitis B in a Child: A Case Report and Literature Review.

Acellular pertussis vaccination facilitates Bordetella parapertussis infection in a rodent model of bordetellosis

Adverse events following immunization with vaccines containing adjuvants.

Aluminum adjuvants of vaccines injected into the muscle: Normal fate, pathology and associated disease.

Association between maternal aluminum exposure and the risk of congenital heart defects in offspring.

A measles outbreak in a middle school with high vaccination coverage and evidence of prior immunity among cases, Beijing, P.R. China

Adverse Events After Routine Immunization of Extremely Low-Birth-Weight Infants

Behavioral abnormalities in female mice following administration of aluminum adjuvants and the human papillomavirus (HPV) vaccine Gardasil.

A two-phase study evaluating the relationship between Thimerosal-containing vaccine administration and the risk for an autism spectrum disorder diagnosis in the United States

Increased Risk of Noninfluenza Respiratory Virus Infections Associated With Receipt of Inactivated Influenza Vaccine

New Concerns about the Human Papillomavirus Vaccine
American College of Pediatricians – January 2016

Insight into the cellular fate and toxicity of aluminium adjuvants used in clinically approved human vaccinations

Administration of aluminium to neonatal mice in vaccine-relevant amounts is associated with adverse long term neurological outcomes. https://www.ncbi.nlm.nih.gov/pubmed/23932735

Human papillomavirus (HPV) vaccine policy and evidence-based medicine: are they at odds?

Exposure to Mercury and Aluminum in Early Life: Developmental Vulnerability as a Modifying Factor in Neurologic and Immunologic Effects https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4344667/

Methodological Issues and Evidence of Malfeasance in Research Purporting to Show Thimerosal in Vaccines Is Safe

Vaccination Attitudes and Practices of Integrative Medicine Physicians.

Reproductive and Developmental Toxicity of Formaldehyde: A Systematic Review

Aluminum Toxicity in Mitochondrial Dysfunction And ASD https://www.scribd.com/.../Aluminum-Toxicity-in...#

Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada. https://www.ncbi.nlm.nih.gov/pubmed/20386731

Vaccination against human influenza A/H3N2 virus prevents the induction of heterosubtypic immunity against lethal infection with avian influenza A/H5N1 virus.

Influenza vaccine effectiveness in the community and the household.

Influenza Vaccination During Pregnancy: A Critical Assessment of the Recommendations of the Advisory Committee on Immunization Practices (ACIP) 

New Quality-Control Investigations on Vaccines: Micro- and Nanocontamination 

What, in Fact, Is the Evidence That Vaccinating Healthcare Workers against Seasonal Influenza Protects Their Patients? A Critical Review

Yearly influenza vaccinations: a double-edged sword?

Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model

Human papillomavirus (HPV) vaccines as an option for preventing cervical malignancies: (how) effective and safe?

A case-control study of quadrivalent human papillomavirus vaccine-associated autoimmune adverse events.

Human papillomavirus vaccine and systemic lupus erythematosus.

Hypothesis: Human papillomavirus vaccination syndrome--small fiber neuropathy and dysautonomia could be its underlying pathogenesis.

Human papilloma virus vaccine and primary ovarian failure: another facet of the autoimmune/inflammatory syndrome induced by adjuvants.

The Introduction of Diphtheria-Tetanus-Pertussis and Oral Polio Vaccine Among Young Infants in an Urban African Community: A Natural Experiment

Pilot comparative study on the health of vaccinated and unvaccinated 6- to 12- year old U.S. children
Adverse events following Haemophilus influenzae type b vaccines in the Vaccine Adverse Event Reporting System, 1990-2013. 

Waning protection after fifth dose of acellular pertussis vaccine in children.

New Quality-Control Investigations on Vaccines: Micro- and Nanocontamination 

Vaccines for preventing influenza in healthy adults

Association between type 1 diabetes and Hib vaccine�https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1116914/

Monday, April 10, 2017

Corruption, Greed, and the "Foreign Hand" Drives Vaccination

Vaccine Vendors' Greed Goes Viral

Free Vaccines Aren't Free of the Foreign Hand

"No Need to Regulate the Private Sector"

Tuesday, April 04, 2017

Bill in India to make Vaccines Mandatory

Vaccinating kids in Tamil Nadu to be made schools' responsibility


All private and public schools will have to submit annual vaccine records to the directorate of public health."We will ask school heads to ensure students are vaccinated. Children who have not taken vaccines will be asked to quit since they can be dangerous to other children. Our aim is to ensure universal coverage," he said.

The government will use provisions of the Madras Public Health, Act, 1939, to make vaccination mandatory , offici als said. Students' vaccination records will be a part of the annual inspection programme where food and water safety, ventilation, and toilets are checked. A dedicated team of 770 doctors and an equal number of nurses also work for the programme."These doctors will vaccinate children who have missed the schedule," said director of public health Dr K Kolandaisamy .

A new bill on public health emergencies allows for dubious restrictions of citizens’ liberties

The Bill empowers medical officers to inspect any premises, isolate people, restrict movement, test a patient and mandate treatment or vaccination of a person suffering from disease. The Bill has does not mention the necessity of seeking consent from citizens for any of these measures.

Friday, March 24, 2017

MMR Vaccination Causes Panic in Africa

Vaccination mishap causes panic in Lesotho

A recently rolled out countrywide Measles, Mumps and Rubella (MMR) vaccination campaign in Lesotho has become a national disaster, with hundreds of immunised children returned to health centres with extreme side-effects and full blown measles symptoms.

Tuesday, February 14, 2017

Bill & Melinda Gates in trouble in india

RSS arm trains its gun on Bill and Melinda Gates foundation

INDIA Updated: Feb 10, 2017 23:57 IST
Smriti Kak Ramachandran

Hindustan Times, New Delhi

Gates Foundation will stop hosting immunisation group but will still back project: Health ministry

A news report had referred to 'conflict of interest issues' in the relationship between the national advisory body and the foundation.


By Fleme Varkey | 11:17 AM Monday, 13 February 2017

Centre shuts Gates on Gates Foundation


Monday, November 14, 2016

237 deaths by Pentavalent vaccine

237 deaths by Pentavalent vaccine and still counting

By JACOB PULIYEL | NEW DELHI | 13 November, 2016
Under Right to Information we know that up to August 2016 there have been 237 deaths reported to the government here within 72 hours of vaccination with Pentavalent. We examined deaths in states which were giving DPT and Pentavalent vaccine concurrently.

Monday, September 12, 2016

Indian Doctors Lash Out at the Vaccination System

New vaccines safe and effective or not? Place all evidence in public domain

  • Yogesh Jain, Sarojini N & Amar Jesani
  •  |  
  • Updated: Aug 25, 2016 21:14 IST
  • http://www.hindustantimes.com/analysis/are-new-vaccines-safe-and-effective-place-all-evidence-in-public-domain/story-yn0CBrn73BjwajsqbzjeaO.html 

A public debate on the addition of new vaccines to the national immunisation schedule has been necessitated by recent developments. First, a few years ago, the hepatitis B vaccine was included in the Universal Immunisation Programme (UIP), which initially included six vaccines. Second, the pentavalent vaccine — a combination vaccine against diphtheria, whooping cough, tetanus, poliomyelitis and hepatitis B — is being introduced in a phased manner in the UIP, with attendant concerns. Third, a slew of new vaccines against rotavirus, rubella, human papilloma virus, pneumococci and the injectable inactivated polio vaccine are under consideration. It is sobering to realise that we still have no vaccine in the works for major infections like dengue and falciparum malaria.
The introduction of new vaccines must be assessed critically for human use in terms of their suitability, safety, protective efficacy and affordability before adopting them into UIP. Moreover, whether the public health system has the organisational capacity to deliver and monitor additional vaccines at an appropriate time, without affecting the coverage of existing vaccines or other health services should be evaluated in accordance with the National Vaccine Policy.
Vaccines are given on a mass scale to healthy people, particularly children, with the expectation of preventing illnesses. This raises vital issues around the availability of clear scientific and epidemiological evidence to rationalise the inclusion of new vaccines. It must also be assessed whether there exist other measures such as improved water quality, health care services, access to food and nutrition, etc. that are more effective and economical in preventing diseases for which vaccines are being considered as solutions. Even if it is argued that both vaccines and improving social determinants to prevent these diseases should be promoted, prioritising vaccines over other measures shifts focus from the latter.
The market impetus behind vaccines can be formidable when they are brought in through large-scale programmes like the UIP in India. The onus of taking a just, socially appropriate and objective decision lies with the Ministry of Health and Family Welfare (MoHFW) and bodies like the National Technical Advisory Group on Immunisation (NTAGI), which provide approvals.
However, neither NTAGI nor any other technical body has brought out guidelines based on rigorous research about the safety and effectiveness of new vaccines, such as the pentavalent and rotavirus ones. All evidence should be placed in the public domain, through technical reports that enumerate their pros and cons. What incidence of side effects is too much for a vaccine to be advised as a preventive health technology? What is an “acceptable” death rate in a vaccination programme? When that occurs, the documentation of adverse events following immunisation, their investigation and determination of the most likely cause must be conducted in a transparent manner. This should be followed by disbursement of compensation to the victims. This would reduce the chasm between those identified as the pro-vaccine lobby and the anti -vaccine one.
Yogesh Jain, Sarojini N & Amar Jesani are public health professionals
The views expressed are personal

PM Modi must rescue vaccine programme from vested interests

By JACOB PULIYEL | 26 March, 2016
e Bill and Melinda Gates Foundation’s (BMGF’s) prescription of foreign drugs for India’s poor and the way in which it has become a major influence within key ministries in Government of India was mentioned in this newspaper recently (The Sunday Guardian, 7 February 2016). The links with the Global Alliance for Vaccine and Immunisation (GAVI) and Public Health Foundation of India (PHFI) were described. The article also highlighted the investments of the foundation and the board members in US-EU Big Pharma stocks and the resulting possible conflict of interests.
The vaccine market in India is potentially one of the largest in the world. The government is advised on what vaccines to include in the national immunisation programme by a committee of experts called the National Technical Advisory Group on Immunisation (NTAGI).
This body is expected to evaluate the vaccines, their costs and benefits for the country. Vaccines whose cost far exceeds the benefits are not to be recommended. But the entire secretariat of the NTAGI has now been outsourced to the BMGF. Called the Immunisation Technical Support Unit (ITSU), the secretariat is funded by the Gates Foundation and has been moved out of the Nirman Bhawan, where the Ministry of Health is located, into the PHFI.
It is as if the resources of the Indian government machinery cannot stretch to pay the salaries of the 32 people in this secretariat. ITSU now puts together the papers supporting vaccines and it decides the agenda of the NTAGI and also controls what is recorded as minutes of the meetings.
To ensure that the public is kept in the dark about how the public health policy on vaccines is formulated, the new secretariat has introduced draconian confidentiality clauses. This is in sharp contrast to what happens in the United States, where anyone from the public can attend the technical advisory meetings and can question the experts on the committee. Also in sharp contrast to the US, where members to the immunisation technical advisory body are selected from among applicants by an independent body, the NTAGI in India is merely nominated by the ministry.
As the committee composition is based on the ministry, decisions cannot be based on a majority of votes, but on the strength of the arguments for or against a vaccine.
This is why the minutes of the meeting are a crucial public record. Recording the arguments of those who dissented against the “majority”, would be a powerful deterrent to reckless and irrational decision making by the “majority”.
To prevent such embarrassing come-backs, the ITSU now records the decisions based on the vote, but not the arguments presented against a vaccine.
The confidentiality clause and the new regime came onto being during the UPA rule in 2013. Prior to that, the minutes recorded the proceedings and the records have come to haunt a majority decisions. Prime  Minister Narendra Modi needs to bring back transparency in its functioning.
The NTAGI introduced Hep B and Hib vaccines in the Universal Immunisation Programme (UIP) when there was evidence presented that they were not needed.
This was compounded by the decision to introduce it as a combined vaccine in the same injection vial with the DPT vaccine—making it a five-in-one Pentavalent vaccine. Each of the three decisions will be discussed individually.
Hepatitis B infection is usually a very mild viral infection that goes undetected by the majority of those who contract it. However, some who acquired the infection around the time of birth develop chronic liver disease and a fatal form of liver cancer. Evidence from India from the Indian Council of Medical Research (ICMR) indicates that the incidence of this problem is vanishingly small.
To make it appear that it was worthwhile to introduce the vaccine, it was made out in 2000 that 250,000 were dying each year because of this cancer, when the real figure was 5,000.
The records show how a fictitious study was quoted saying liver biopsies were performed in all Hepatitis B carriers in AIIMS, to push for the use of the vaccine.
Ten years after the vaccine was introduced in Andhra Pradesh, a study in 2014 was done by the ICMR to look for benefits.
The data proved what was to be anticipated—that the vaccination programme has been completely useless and children who received the vaccine were no better than the controls studied who had not received the vaccine.
Admittedly, it is embarrassing to have a paper trail showing that these facts were obvious before India launched this expensive programme. The vaccination programme however continues unhindered by these facts
The story with Hib vaccine is similar. Hib is a bacterial infection that can result in pneumonia or meningitis. But the incidence of this is so low as to make the vaccine redundant.
An editorial in the Bulletin of the WHO suggested that this vaccine was not needed in Asia. Studies in Bangladesh demonstrated the vaccine was not useful in reducing meningitis or pneumonia.
Immediately after the results of the Bangladesh study were known in 2006, a misleading press release was issued by a number of organisations including the WHO GAVI, USAID and the “Hib Initiative”, stating that the “Bangladesh study showed Hib vaccine protects children from life-threatening pneumonia and meningitis!”
The WHO, in 2006, followed this with a recommendation that Hib vaccines should be included in all routine infant immunisation programmes. The involvement of international organisations was exposed in the British Medical Journal.
In 2007, in a self-congratulatory article, GAVI and the “Hib initiative” described how they turned the tide in favour of the Hib vaccine by getting the WHO to call for universal vaccine introduction in all countries in spite of controversies about the low burden of disease in some countries.
The Hepatitis B and the Hib vaccines, although next to useless in India given the low burden of disease, at least were relatively safe. However, it was introduced in 2011 as a combination vaccine along with the triple vaccine against diphtheria, whooping cough and tetanus (DPT vaccine), making the new vaccine a five-in-one vaccine, or Pentavalent vaccine. This was recommended by the NTAGI in spite of concerns about the safety of the combined vaccine. Prior to its use in India, it had been used in Sri Lanka. Here, three deaths were probably caused by the vaccine and there was no other plausible reason found on detailed investigation of the deaths. The experts, however, seem to have violated the standard protocol for classification of adverse events and reported the deaths were unlikely to be caused by the vaccine. This was exposed in the British Medical Journal in 2010. When it was introduced in India, the NTAGI had noted these safety issues and stipulated that the vaccine be introduced only in Tamil Nadu and Kerala for a year. After the yearlong study was over, the safety of the vaccine was to be evaluated before it was introduced in other states.
There was a death on the first day of the use of the vaccine in Kerala on 15 December 2011. There were at least 12 deaths in Kerala before the year was over. Rather than evaluate the safety of the vaccine, the government introduced the vaccine in other states before 2012 was over, in clear violation of the explicit conditions laid down the NTAGI. This matter was raised in the NTAGI and an NTAGI sub-committee was set up to evaluate all the deaths from the Pentavalent vaccine. This committee met for one preliminary meeting on 22.4. 2013, but in spite of repeated requests the committee never met again. The fact that these decisions of the NTAGI were recorded in the minutes caused more than a little awkwardness for the people who were responsible. There have now been over 100 deaths soon after this vaccine was administered, but the NTAGI sub-committee has not been allowed to evaluate the deaths. A study done by the German government, called the TOKEN study, has shown that the Pentavalent vaccine results in sudden unexplained deaths in children within 48 hours of vaccination.
But Government of India under UPA ignored this. Hopefully the NDA will make amends.
In spite of the stance of denial by the government, the public are getting wary. As a result, people are losing faith in vaccines itself. The NFHS data from Tamil Nadu, which had 90% immunisation a few years ago, has come down to a mere 56%. The result is that essential vaccines like DPT are not being received by children. These are a basic right to the health of babies in India. As a consequence, diphtheria is on the upsurge in these areas. We cannot allow this to happen in the country.
This is happening because the emphasis is on introducing new and expensive vaccines against minor ailments, while ignoring serious diseases against which affordable vaccines are easily available.
In 2013, a decision was taken by the UPA to outsource the secretariat of vaccine policymaking to the BMGF without any public discussion. That will have to be reversed and the secretariat will have to be made part of the Ministry of Health. The selection of members to this advisory body must be made on merit by an independent body and they must be held responsible for their advice. When Facebook tried to dilute net neutrality with their offering of free basics, a public outcry and a nationalist regulatory authority stopped them on their tracks. A similar reaction is crucial if we are to eliminate vested interests from controlling public health policy and its horrendous consequences for the country. The nation looks to PM Modi to ensure that truth prevails in this critical field of national endeavour.
Jacob Puliyel, the head of Paediatrics at St Stephens Hospital, Delhi, can be contacted at Puliyel@gmail.com

Is India's public health in good hands? Probably not with PHFI running the show


 In 2011, the Union Health Ministry conducted an investigation into 54 infant deaths in Tamil Nadu, concluding that 'adverse events following immunisation' (AEFI) were observed after administering Pentavalent. In Vietnam, since the vaccine was first used in 2007, at least 63 children have died after vaccination. Vietnam's health ministry suspended the vaccine in May 2013 after the death of nine children.
However, the reply to an RTI filed by various NGOs showed that the strategic plan for the Universal Immunisation Programme (UIP) prepared by the PHFI for the government suggested that the Health Ministry double its spend on Pentavalent from Rs 312.7 crore in 2013 to Rs 773.8 crore in 2017.
"The ministry's decision is to go ahead with the plan of investing in Pentavalent," said a ministry source.